Human herpesvirus 8 (HHV-8), a causative agent for Kaposi’s sarcoma, was identified
In 1994, human herpesvirus 8 (HHV-8), a causative agent for Kaposi’s sarcoma (KS), was identified. HHV-8 is also…
Washington University – St Louis researchers developed a blood test to detect a thyroid cancer gene mutation
In 1994, researcher Helen Donis-Keller and colleagues at Washington University – St. Louis announced they had for the…
Infectious molecular clone of a human T-cell leukemia virus was developed at Washington University – St Louis
In 1994, Washington University – St. Louis reseacher Lee Ratern, MD and colleagues announced they had developed an…
Colon cancer gene was identified
On Dec. 2, 1993, Dana-Farber scientists identified the gene that causes an inherited form of colon cancer, which…
The NIH Revitalization Act of 1993, PL 103-43, was signed
On Jun. 10, 1993, the NIH Revitalization Act of 1993, P.L. 103-43, was signed. The act encouraged the…
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
The Pappajohn Clinical Cancer Center opens for service
In 1993, the John and Mary Pappajohn Clinical Cancer Center opened for service after receiving a generous $25…
The Prostate, Lung, Colorectal, and Ovarian trial began recruiting 148,000 men and women, ages 55-74
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched The trial was designed to determine whether…
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
The Hollings Cancer Center was founded
In 1993, The Hollings Cancer Center (HCC) was formally was established and named for former U.S. Senator and…
Vanderbilt Cancer Center was established
In 1993, the Vanderbilt Cancer Center was established under the leadership of Dr. Hal Moses, to bring together…
The Cancer Therapy & Research Center at San Antonio received NCI designation
In 1993, The Cancer Therapy & Research Center (CTRC) at San Antonio received National Cancer Institute (NCI) designation….
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Jon M and Karen Huntsman donated $10 million to the University of Utah to establish a cancer institute
In 1993, Jon M. and Karen Huntsman donated $10 million to the University of Utah to establish a…
Immunex merged with American Cyanamid’s Lederle Oncology business
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
The Mammography Quality Standards Act was passed
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress….
Pacific Health Research Institute was awarded the multi-center ‘Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial’
In 1992, the National Cancer Institute awarded the Pacific Health Research Institute its largest and most enduring project….
The Indiana University Cancer Center was founded
In 1992, The Indiana University (IU) Cancer Center, now known as the IU Melvin and Bren Simon Comprehensive…
OHSU President Peter O Kohler, MD appointed Grover Bagby, MD, director of the Oregon Cancer Center
In 1992, Oregon Health & Science University (OHSU) President Peter O. Kohler, M.D. announced the appointment of Grover…
The Oregon Cancer Center was founded at Oregon Health & Science University
In 1992, the Oregon Cancer Center, later known as the OHSU Cancer Institute, was founded at Oregon Health…
Dendreon Corporation was founded
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…
Cell Therapeutics was incorporated
On Sept. 4, 1991, Cell Therapeutics, also known as CTI BioPharma, was incorporated by two oncologists, Drs. James…
Post-operative (adjuvant) radiation therapy and chemotherapy are found to improve survival in rectal cancer
On Mar. 4, 1991, researchers reported that post-operative (adjuvant) radiation therapy and chemotherapy were found to improve survival…
The first human gene therapy to treat cancer was started
On Jan. 29, 1991, the first human gene therapy to treat cancer was started at the National Cancer…
The University of Michigan Rogel Cancer Center received Comprehensive NCI designation
In 1991, the University of Michigan Rogel Cancer Center received National Cancer Institute (NCI) comprehensive center designation. The…
US Senator Alan Cranston underwent state-of-the-art procedure at Stanford University Hospital to attack his prostate cancer
In 1991, U.S. Senator Alan Cranston (D-Calif.) underwent a state-of-the-art procedure at Stanford University Hospital to attack his…
The CDC began developing a national strategic plan for early detection and control of breast and cervical cancers
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
Stoddard Cancer Center opened at Iowa Methodist Medical Center
In 1991, Stoddard Cancer Center, now part of UnityPoint Health, opened at Iowa Methodist Medical Center. In 1990,…
The Northwestern University Cancer Center was renamed in honor of Robert H Lurie
In 1991, The Northwestern University Cancer Center was dedicated through an endowment gift from Ann and Robert H….